L-2-amino-4-phosphonobutyric acid (or L-AP4) is a drug used in scientific research, which acts as a group-selective agonist for the group III metabotropic glutamate receptors (mGluR4/6/7/8). It was the first ligand found to act as an agonist selective for this group of mGlu receptors, but does not show selectivity between the different mGluR Group III subtypes. It is widely used in the study of this receptor family and their various functions.
^Lopez, S, Turle-Lorenzo, N, Acher, F, De Leonibus, E, Mele, A, Amalric, M (2007). "Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease". Journal of Neuroscience27 (25): 6701–11. doi:10.1523/JNEUROSCI.0299-07.2007. PMID17581957.
^MacInnes, N, Duty, S (2008). "Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo". European Journal of Pharmacology580 (1–2): 95–9. doi:10.1016/j.ejphar.2007.10.030. PMID18035348.
^MacIejak, P, Szyndler, J, Turzyńska, D, Sobolewska, A, Taracha, E, Skórzewska, A, Lehner, M, Bidziński, A, Hamed, A, Wisłowska-Stanek, Aleksandra, Płaźnik, Adam (2009). "The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration". Brain Research1282: 20–7. doi:10.1016/j.brainres.2009.05.049. PMID19481536.